knee osteoarthritis
Conditions
Interventions
Experimental group:Transcutaneous electrical nerve stimulation combined with sham transcranial direct current stimulation
Control group:Transcutaneous electrical nerve stimulation combined with transcranial direct current stimulation
Sponsors
Dushu Lake Hospital affiliated to Soochow University
Eligibility
Sex/Gender
All
Age
60 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. People with mild KOA; 2. Age between 60-70 years; 3. Conscious and had full capacity for civil conduct; 4. Subjects who were willing to cooperate with the trial.
Exclusion criteria
Exclusion criteria: 1. Patients undergoing physical therapy or surgery; 2. Those who experience more severe pain in other parts of the body than in the knee joint, and whose physical activity is severely hindered; 3. Patients who use life-sustaining drugs; 4. Subjects who did not sign an informed consent form or were deemed ineligible to participate in this experiment; 5. Patients with contraindications for intervention: a. Patients who have undergone tibial osteotomy, artificial joint replacement, and infectious knee joint disease; b. Patients who have received intra-articular hormone or sodium hyaluronate injections within the past three months; c. Patients with knee joint sensory disorders caused by tumors/knee joint hyperosteogeny/lower limb vascular diseases/rheumatoid arthritis/acute periarthritis of the knee joint (including knee joint OA and inflammatory rheumatoid arthritis)/purulent arthritis, fractures or unilateral meniscus injuries/acute sports knee joint injuries; d. Patients with acute or chronic uncompensated diseases (such as uncontrolled hypertension, chronic obstructive pulmonary disease, heart disease, heart failure or diabetes), epilepsy, skin diseases, etc; e. Equipped with brain medical devices or implanted brain metal devices, or having used life-saving medical electronic devices such as pacemakers, artificial hearts/lungs, or using wearable medical electronic devices; f. Prohibit having cognitive impairment, severe depression, or a history of syncope; g. Allergic constitution and pregnant women are prohibited.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale;Step length;Cadence;6-minute walk test;Range of motion;Quadriceps strength; | — |
Secondary
| Measure | Time frame |
|---|---|
| Short Form-36 Health Survey; | — |
Countries
China
Contacts
Public ContactMin Su
Dushu Lake Hospital affiliated to Soochow University
Outcome results
None listed